SCHEMBL7326267

SCHEMBL7326267

COCC#Cc1ccc(C[C@H](NC(=O)[C@@H]2CCCN2S(=O)(=O)c2ccc(C)cc2)C(=O)O)cc1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ITGA4 P13612 6/20 0.60
ITGB1 P05556 8/20 0.57
ITGA5 P08648 3/20 0.57
ALDH1A1 P00352 1/20 0.51
ITGAV P06756 2/20 0.50
ITGB7 P26010 2/20 0.48
MMP2 P08253 1/20 0.48
MMP9 P14780 1/20 0.48
ITGA2 P17301 1/20 0.47
FKBP1A P62942 1/20 0.47
MAPK1 P28482 2/20 0.47
TSHR P16473 1/20 0.47
RAB9A P51151 1/20 0.46
GAA P10253 1/20 0.46
HPGD P15428 1/20 0.46
MAPT P10636 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7326273 1.00 ITGA4 (0.60) ITGA4ITGB1ITGA5ALDH1A1ITGAV
SCHEMBL7506837 0.91 ITGA4 (0.52) ITGA4ITGB1ITGA5ALDH1A1ITGAV
SCHEMBL7511565 0.91 ITGA4 (0.52) ITGA4ITGB1ITGA5ALDH1A1ITGAV
SCHEMBL7312726 0.91 ITGB1 (0.59) ITGA4ITGB1ITGA5ALDH1A1ITGAV
SCHEMBL7312728 0.91 ITGB1 (0.59) ITGA4ITGB1ITGA5ALDH1A1ITGAV
SCHEMBL7325788 0.90 ITGA4 (0.60) ITGA4ITGB1ITGA5ALDH1A1ITGAV
SCHEMBL7325791 0.90 ITGA4 (0.60) ITGA4ITGB1ITGA5ALDH1A1ITGAV
SCHEMBL7315484 0.88 ITGA4 (0.57) ITGA4ITGB1ITGA5ALDH1A1ITGAV
SCHEMBL7315477 0.88 ITGA4 (0.57) ITGA4ITGB1ITGA5ALDH1A1ITGAV
SCHEMBL7316216 0.87 ITGA4 (0.59) ITGA4ITGB1ITGA5ALDH1A1ITGAV

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6492421-B1 BINDING VERY LATE ANTIGEN-4; INFLAMMATORY DISEASES SUCH AS ASTHMA, ALZHEIMER'S DISEASE, ATHEROSCLEROSIS, AIDS, DEMENTIA, DIABETES, INFLAMMATORY BOWEL DISEASE, RHEUMATOID ARTHRITIS, TISSUE TRANSPLANTATION, TUMOR METASTASIS, MYOCARDIAL ISCHEMIA ATHENA NEUROSCIENCES, INC. 2002-12-10 US claimed
EP-1001972-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-24 EP claimed
WO-1999006431-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO claimed
US-6492421-B1 BINDING VERY LATE ANTIGEN-4; INFLAMMATORY DISEASES SUCH AS ASTHMA, ALZHEIMER'S DISEASE, ATHEROSCLEROSIS, AIDS, DEMENTIA, DIABETES, INFLAMMATORY BOWEL DISEASE, RHEUMATOID ARTHRITIS, TISSUE TRANSPLANTATION, TUMOR METASTASIS, MYOCARDIAL ISCHEMIA ATHENA NEUROSCIENCES, INC. 2002-12-10 US disclosed
EP-1001972-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 Elan Pharmaceuticals, Inc. (US) 2000-05-24 EP disclosed
WO-1999006431-A1 SUBSTITUTED PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 ELAN PHARMACEUTICALS, INC. (US) 1999-02-11 WO disclosed